Clinical Trial Update: Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women [Phase 4]

View source ↗

Summary

Phase 4 trial update examining oral contraceptives' effects on insulin resistance and cardiovascular risk profile in pre-menopausal women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Risk
• Insulin Sensitivity

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Insulin Sensitivity, Cardiovascular Risk | Phase 4 | Status: COMPLETED | Results posted: 2018-07-10